07:31 AM EDT, 05/30/2024 (MT Newswires) -- Roivant Sciences ( ROIV ) reported a fiscal Q4 net loss Thursday of $0.19 per diluted share, widening from a loss of $0.05 a year earlier.
Analysts polled by Capital IQ expected a loss of $0.30.
Net revenue for the quarter ended March 31 was $28.9 million, up from $27.4 million a year earlier.
Analysts surveyed by Capital IQ expected $30.9 million.